Clinical Trials Directory

Trials / Completed

CompletedNCT04115176

GCF IL-17 Levels and Oxidative Status of Smoking and Non-smoking Individuals With Periodontitis

Smoking Effects on GCF GCF IL-17A AND IL-17 Levels and Oxidative Status of Patients Receiving Periodontal Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Ondokuz Mayıs University · Academic / Other
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study was performed to evaluate the effects of both periodontal treatment and smoking on the gingival crevicular fluid(GCF) levels of interleukin (IL)-17A, IL-17E, Total oxidative stress(TOS) and total antioxidant capasity(TAOC) in smoking and non-smoking patients with severe chronic periodontitis. Systemically healthy 15 smoker,15 non-smoker with chronic periodontitis were attended for the study. Periodontal status were determined by recording periodontal clinical measurements. GCF samples were collected at the baseline, at the end of initial periodontal treatment and 4 weeks after periodontal flap surgery. The data were tested statistically by the Student t and paired sample t tests.

Conditions

Timeline

Start date
2017-10-10
Primary completion
2019-07-10
Completion
2019-07-10
First posted
2019-10-03
Last updated
2019-10-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04115176. Inclusion in this directory is not an endorsement.